<!DOCTYPE html>
<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]-->
<!--[if IE 7]>         <html class="no-js lt-ie9 lt-ie8"> <![endif]-->
<!--[if IE 8]>         <html class="no-js lt-ie9"> <![endif]-->
<!--[if gt IE 8]><!--><html class="no-js"> <!--<![endif]-->
    <head>
        <meta charset='utf-8'>
        <meta http-equiv='X-UA-Compatible' content='IE=edge,chrome=1'>
        <title>DC Code - Chapter 8G. Prescription Drug Monitoring.</title>
        <meta property='st:title' content='Chapter 8G. Prescription Drug Monitoring.' />
        <meta name='description' content='A simple, free browser for the Washington, DC Code'>
        <meta name='viewport' content='width=device-width'>
        <link href='http://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700' rel='stylesheet' type='text/css'>
        <link rel='stylesheet' type='text/css' href='/css/reset.css' media='screen' />
        <link rel='stylesheet' type='text/css' href='/css/site.css' media='screen' />
        <link rel='stylesheet' type='text/css' href='/css/body.css' media='screen' />
        <link rel='stylesheet' type='text/css' href='/css/print.css' media='print' />
        <link rel='stylesheet' type='text/css' href='/css/icons/style.css' media='screen' />
    </head>
    <body>
            <header>
                <div class="container">
                <div class='right no-print'>
                    <!-- <form id='search-form'>
                        <form>
                            <input type="text" id="st-search-input" class="st-search-input" />
                        </form>
                    </form> -->
                </div>
                <h1 id='sitename'><a href='/'>Code of the District of Columbia (Unofficial)</a></h1>
            </div>
            </header>
            <div class='main container'>
                <div class='clearfix' style='width: 100%;'>
                    <div id='sidebar' class='col4 quiet'>
                        
                            <h2>You Are Here</h2>
                            <ul class="ancestors">
                            
                                <li><a href='/'>Code of the District of Columbia</a></li>
                            
                                <li>↪ <a href='/Title-48/'>Title 48. Foods and Drugs.</a></li>
                            
                            <li>↪ Chapter 8G. Prescription Drug Monitoring.</a></li>
                            </ul>
                        

                        
                            <h2>Previous</h2>
                            <p><a href="/Title-48/Chapter-8F/">Chapter 8F. Safe Disposal of Unused Pharmaceuticals.</a></p>
                        

                        
                            <h2>Next</h2>
                            <p><a href="/Title-48/Chapter-9/">Chapter 9. Controlled Substances Act.</a></p>
                        

                        <h2>Publication Information</h2>
                        <h3>Current through April 13, 2015</h3>
                        <dl id="recency">
                            <dt>Last codified D.C. Law:</dt>
                            <dd>Law 20-241 effective April 13, 2015</dd>
                            <dt>Last codified Emergency Law:</dt>
                            <dd>Act 20-617 effective January 28, 2015</dd>
                            <dt>Last codified Federal Law:</dt>
                            <dd>Public Law 113-235 approved December 16, 2014</dd>
                        </dl>
                    </div>
                    <div class='col8'>
                        <div id='content'>
                            <div class="line-group line-group-page-heading">
    <h1 data-swiftype-index='true'>Chapter 8G. Prescription Drug Monitoring.</h1>
</div>

<div data-swiftype-index='true'>

    
        

    

    

    <div class="line-group toc ">
        

    
        <div class="line child-link " style="text-indent: 0em">
            
                <div>
                    <span class="title"><a href="/sections/48-853.01.html" class="internal-link">§ 48–853.01. Definitions.</a></span>
                </div>
                
            
        </div>
    
        <div class="line child-link " style="text-indent: 0em">
            
                <div>
                    <span class="title"><a href="/sections/48-853.02.html" class="internal-link">§ 48–853.02. Program establishment; Director’s authority.</a></span>
                </div>
                
            
        </div>
    
        <div class="line child-link " style="text-indent: 0em">
            
                <div>
                    <span class="title"><a href="/sections/48-853.03.html" class="internal-link">§ 48–853.03. Reporting requirements; exceptions.</a></span>
                </div>
                
            
        </div>
    
        <div class="line child-link " style="text-indent: 0em">
            
                <div>
                    <span class="title"><a href="/sections/48-853.04.html" class="internal-link">§ 48–853.04. Authority to access database.</a></span>
                </div>
                
            
        </div>
    
        <div class="line child-link " style="text-indent: 0em">
            
                <div>
                    <span class="title"><a href="/sections/48-853.05.html" class="internal-link">§ 48–853.05. Confidentiality of data; disclosure of information; discretionary authority of the Director.</a></span>
                </div>
                
            
        </div>
    
        <div class="line child-link " style="text-indent: 0em">
            
                <div>
                    <span class="title"><a href="/sections/48-853.06.html" class="internal-link">§ 48–853.06. Interoperability; information exchange with other prescription drug monitoring programs.</a></span>
                </div>
                
            
        </div>
    
        <div class="line child-link " style="text-indent: 0em">
            
                <div>
                    <span class="title"><a href="/sections/48-853.07.html" class="internal-link">§ 48–853.07. Criteria for indicators of misuse; Director’s authority to disclose information; intervention.</a></span>
                </div>
                
            
        </div>
    
        <div class="line child-link " style="text-indent: 0em">
            
                <div>
                    <span class="title"><a href="/sections/48-853.08.html" class="internal-link">§ 48–853.08. Immunity from liability.</a></span>
                </div>
                
            
        </div>
    
        <div class="line child-link " style="text-indent: 0em">
            
                <div>
                    <span class="title"><a href="/sections/48-853.09.html" class="internal-link">§ 48–853.09. Unlawful disclosure of information and acts; disciplinary action authorized; penalties.</a></span>
                </div>
                
            
        </div>
    
        <div class="line child-link " style="text-indent: 0em">
            
                <div>
                    <span class="title"><a href="/sections/48-853.10.html" class="internal-link">§ 48–853.10. Rules.</a></span>
                </div>
                
            
        </div>
    

    </div>

    <div class="line-group primary-content ">
        

    
        <div class="line  " style="text-indent: 1.25em">
            
                <hr>
            
        </div>
    

    </div>

    <div class="line-group toc ">
        

    
        <div class="line heading heading-1 " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">§ 48–853.01. Definitions.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group primary-content ">
        

    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">For the purposes of this chapter, the term:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">“Administer” shall have the same meaning as provided in <a href='/sections/48-901.02.html'>§ 48‑901.02(1)</a>.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">“Controlled substance” shall have the same meaning as provided in <a href='/sections/48-901.02.html'>§ 48‑901.02(4)</a>.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(3) </span>
                
                    <span class="" style="">“Controlled Substances Act” means Unit A of Chapter 9 of this title [<a href='/sections/48-901.01.html'>§ 48‑901.01</a> et seq.].</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(4) </span>
                
                    <span class="" style="">“Covered substance” means all controlled substances included in the schedules set forth in §§ <a href='/sections/48-902.06.html'>48‑902.06</a>, <a href='/sections/48-902.08.html'>48‑902.08</a>, <a href='/sections/48-902.10.html'>48‑902.10</a>, and <a href='/sections/48-902.12.html'>48‑902.12</a>, in schedules II through V of section 202(c) of Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970, approved October 27, 1970 (<a href='http://api.fdsys.gov/link?collection=statute&volume=84&page=1247'>84 Stat. 1247</a>; 21 U.S.C. § 812), and any other drug, as specified by rulemaking, that is required to be reported to the Prescription Drug Monitoring Program pursuant to this chapter.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(5) </span>
                
                    <span class="" style="">“Department” means the Department of Health.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(6) </span>
                
                    <span class="" style="">“Director” means the Director of the Department of Health.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(7) </span>
                
                    <span class="" style="">“Dispense” shall have the same meaning as provided in <a href='/sections/48-901.02.html'>§ 48‑901.02(7)</a>.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(8) </span>
                
                    <span class="" style="">“Dispenser” means a practitioner who dispenses a covered substance to the ultimate user, or his or her agent, but shall not include:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(A) </span>
                
                    <span class="" style="">A licensed hospital or institutional facility pharmacy that distributes covered substances for the purpose of inpatient hospital care or the dispensing of prescriptions for controlled substances at the time of discharge from such a facility;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(B) </span>
                
                    <span class="" style="">A practitioner or other authorized person who administers a covered substance;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(C) </span>
                
                    <span class="" style="">A wholesale distributor of a covered substance; or</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(D) </span>
                
                    <span class="" style="">A clinical researcher providing a covered substance to research subjects as part of a research study approved by a hospital-based institutional review board or an institutional review board accredited by the association for the accreditation of human research protections programs.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(9) </span>
                
                    <span class="" style="">“Drug” means:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(A) </span>
                
                    <span class="" style="">Any substance recognized as a drug, medicine, or medicinal chemical in the official United States Pharmacopoeia, official National Formulary, official Homeopathic Pharmacopoeia, or official Veterinary Medicine Compendium or other official drug compendium or any supplement to any of them;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(B) </span>
                
                    <span class="" style="">Any substance intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animal;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(C) </span>
                
                    <span class="" style="">Any chemical substance, other than food, intended to affect the structure or any function of the body of man or other animal; and</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(D) </span>
                
                    <span class="" style="">Any substance intended for use as a component of any items specified in subparagraph (A), (B), or (C) of this paragraph, but does not include medical devices or their components, parts, or accessories.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(10) </span>
                
                    <span class="" style="">“Health occupations board” means a board that, pursuant to <a href='/sections/3-1204.08.html'>§ 3‑1204.08</a>, licenses and regulates health professionals with the authority to prescribe or dispense covered substances.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(11) </span>
                
                    <span class="" style="">“Interoperability” means, with respect to a District of Columbia or state prescription drug monitoring program, the ability of that program to share electronically reported prescription information with another state, district, or territory of the United States’ prescription drug monitoring program or a third party, approved by the Director, that operates interstate prescription drug monitoring exchanges.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(12) </span>
                
                    <span class="" style="">“Patient” means the person or animal who is the ultimate user of a controlled substance or other drug required to be submitted under this chapter for whom a lawful prescription is issued or for whom a controlled substance or such other drug is lawfully dispensed.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(13) </span>
                
                    <span class="" style="">“Practitioner” shall have the same meaning as provided in <a href='/sections/48-901.02.html'>§ 48‑901.02(20)</a>.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(14) </span>
                
                    <span class="" style="">“Prescriber” means a practitioner or other authorized person who prescribes a controlled substance or other covered substance in the course of his or her professional practice.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(15) </span>
                
                    <span class="" style="">“Prescription drug monitoring program” means a program that collects, manages, analyzes, and provides information regarding covered substances or other drugs required to be submitted under this chapter or a program established by a similar act in another state, district, or territory of the United States.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(16) </span>
                
                    <span class="" style="">“Program” means the Prescription Drug Monitoring Program established by <a href='/sections/48-853.02.html'>§ 48‑853.02</a>.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(17) </span>
                
                    <span class="" style="">“Ultimate user” shall have the same meaning as provided in <a href='/sections/48-901.02.html'>§ 48‑901.02(23)</a>.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group annotations ">
        

    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">History</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">(Feb. 22, 2014, <a href='http://openlims.org/public/L20-66.pdf'>D.C. Law 20-66</a>, § 2, <a href='http://www.dcregs.dc.gov/Gateway/IssueList.aspx?IssueYear=2014'>61 DCR 7</a>.)</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Legislative history of Law 20-66</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style=""><a href='http://openlims.org/public/L20-66.pdf'>Law 20-66</a>, the “Prescription Drug Monitoring Program Act of 2013,” was introduced in Council and assigned Bill No. 20-127. The Bill was adopted on first and second readings on November 5, 2013, and December 3, 2013, respectively. Signed by the Mayor on December 20, 2013, it was assigned Act No. 20-232 and transmitted to Congress for its review. <a href='http://openlims.org/public/L20-66.pdf'>D.C. Law 20-66</a> became effective on February 22, 2014.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group toc sep">
        

    
        <div class="line heading heading-1 " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">§ 48–853.02. Program establishment; Director’s authority.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group primary-content ">
        

    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(a) </span>
                
                    <span class="" style="">There is established the Prescription Drug Monitoring Program within the Department. The Program shall:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">Establish, maintain, and administer an electronic system to monitor the dispensing of covered substances;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">Provide dispensers with a basic file layout to enable electronic transmission of the information required under this chapter; and</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(3) </span>
                
                    <span class="" style="">Establish and maintain a process for verifying the credentials of and authorizing the use of prescription information by those individuals and agencies listed in <a href='/sections/48-853.05.html'>§ 48‑853.05(b)</a> and (c).</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(b) </span>
                
                    <span class="" style="">The Director may contract with another District agency or a private vendor as may be necessary for the implementation and maintenance of the Program. Any such contractor shall be bound to comply with the provisions regarding confidentiality of data in this chapter and shall be subject to the penalties specified in this chapter.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(c) </span>
                
                    <span class="" style="">The Director shall also establish a multi-discipline advisory committee, which shall function under the Department to assist in the implementation and evaluation of the Program.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group annotations ">
        

    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">History</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">(Feb. 22, 2014, <a href='http://openlims.org/public/L20-66.pdf'>D.C. Law 20-66</a>, § 3, <a href='http://www.dcregs.dc.gov/Gateway/IssueList.aspx?IssueYear=2014'>61 DCR 7</a>.)</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Section references</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">This section is referenced in <a href='/sections/48-853.01.html'>§ 48‑853.01</a>.</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Legislative history of Law 20-66</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">See note to <a href='/sections/48-853.01.html'>§ 48‑853.01</a>.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group toc sep">
        

    
        <div class="line heading heading-1 " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">§ 48–853.03. Reporting requirements; exceptions.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group primary-content ">
        

    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(a) </span>
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">Each dispenser shall submit to the Program the required reporting information for each prescription dispensed for a covered substance within 24 hours after the covered substance is dispensed, unless otherwise established by the Director through rulemaking, but this does not include merely placing the covered substance prescription into a bin for pickup by the ultimate user or his or her agent.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">Any dispenser located outside the boundaries of the District that is licensed or registered by the District, shall submit the required reporting information to the Program for each prescription dispensed for a covered substance to an ultimate user who resides within the District within 24 hours after the date that the covered substance is dispensed, unless otherwise established by the Director through rulemaking.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(b) </span>
                
                    <span class="" style="">The failure of any person subject to the reporting requirements of this chapter to report the dispensing of a covered substance, unless otherwise exempted under this chapter, or the willful failure to transmit accurate information shall constitute grounds for:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">The revocation, suspension, or denial of a District controlled substances registration;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">Disciplinary action by the relevant health occupations board pursuant to <a href='/sections/3-1205.14.html'>§ 3‑1205.14(c)</a>; and</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(3) </span>
                
                    <span class="" style="">The imposition of civil fines pursuant to <a href='/sections/2-1801.04.html'>§ 2‑1801.04</a>.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(c) </span>
                
                    <span class="" style="">Upon dispensing a covered substance, the dispenser of the covered substance shall report the following information to the Program:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">Patient name;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">Patient address;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(3) </span>
                
                    <span class="" style="">Patient date of birth;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(4) </span>
                
                    <span class="" style="">Patient gender;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(5) </span>
                
                    <span class="" style="">Dispenser identification number;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(6) </span>
                
                    <span class="" style="">Prescriber identification number;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(7) </span>
                
                    <span class="" style="">Date prescription was issued by prescriber;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(8) </span>
                
                    <span class="" style="">Date prescription was dispensed;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(9) </span>
                
                    <span class="" style="">Prescription number;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(10) </span>
                
                    <span class="" style="">Prescription type, whether the prescription is new or is a refill;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(11) </span>
                
                    <span class="" style="">National Drug Code for the drug dispensed;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(12) </span>
                
                    <span class="" style="">Quantity dispensed;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(13) </span>
                
                    <span class="" style="">Number of days’ supply dispensed;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(14) </span>
                
                    <span class="" style="">Number of refills ordered;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(15) </span>
                
                    <span class="" style="">Source of payment for the prescription; and</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(16) </span>
                
                    <span class="" style="">Any other required information as specified in the regulations promulgated by the Director to implement this chapter, or as required for the Program to be eligible to receive federal funds.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(d) </span>
                
                    <span class="" style="">Each dispenser shall transmit the required reporting information in accordance with the manner, format, standards, and schedules established by the Director through rulemaking.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(e) </span>
                
                    <span class="" style="">The reporting requirements of this chapter shall not apply to the dispensing of covered substances when the dispensing is limited to the following:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">Administering covered substances;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">Dispensing covered substances within an appropriately licensed narcotic maintenance program;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(3) </span>
                
                    <span class="" style="">Dispensing covered substances to inpatients in hospitals or nursing facilities licensed by the Department or facilities that are otherwise authorized by law to operate as hospitals or nursing homes in the District;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(4) </span>
                
                    <span class="" style="">Dispensing covered substances to inpatients in hospices licensed by the Department; or</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(5) </span>
                
                    <span class="" style="">Dispensing covered substances as otherwise provided in the Department’s regulations.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group annotations ">
        

    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">History</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">(Feb. 22, 2014, <a href='http://openlims.org/public/L20-66.pdf'>D.C. Law 20-66</a>, § 4, <a href='http://www.dcregs.dc.gov/Gateway/IssueList.aspx?IssueYear=2014'>61 DCR 7</a>.)</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Legislative history of Law 20-66</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">See note to <a href='/sections/48-853.01.html'>§ 48‑853.01</a>.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group toc sep">
        

    
        <div class="line heading heading-1 " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">§ 48–853.04. Authority to access database.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group primary-content ">
        

    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">A prescriber or dispenser authorized to access the information in the possession of the Program pursuant to this chapter may delegate, pursuant to regulations promulgated by the Director to implement the provisions of this section, such authority to up to 2 health care professionals who are:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">Licensed, registered, or certified by a health occupations board; and</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">Employed at the same facility and under the direct supervision of the prescriber or dispenser.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group annotations ">
        

    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">History</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">(Feb. 22, 2014, <a href='http://openlims.org/public/L20-66.pdf'>D.C. Law 20-66</a>, § 5, <a href='http://www.dcregs.dc.gov/Gateway/IssueList.aspx?IssueYear=2014'>61 DCR 7</a>.)</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Legislative history of Law 20-66</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">See note to <a href='/sections/48-853.01.html'>§ 48‑853.01</a>.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group toc sep">
        

    
        <div class="line heading heading-1 " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">§ 48–853.05. Confidentiality of data; disclosure of information; discretionary authority of the Director.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group primary-content ">
        

    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(a) </span>
                
                    <span class="" style="">All data, records, and reports relating to the prescribing and dispensing of covered substances to patients and any abstracts from such data, records, and reports that are in the possession of the Program pursuant to this chapter and any materials relating to the operation or safety of the Program shall be confidential and shall be exempt from disclosure based on requests made pursuant to subchapter II of Chapter 5 of Title 2 [<a href='/sections/2-531.html'>§ 2‑531</a> et seq.]. Information obtained pursuant to the Program may only be disclosed as provided in this chapter.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(b) </span>
                
                    <span class="" style="">Upon receiving a request for information in accordance with the Department’s regulations and in compliance with applicable District and federal laws and regulations, the Director shall disclose information relevant to:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">A specific investigation of a specific patient or of a specific dispenser or prescriber to an agent designated by the Chief of the Metropolitan Police Department to conduct drug diversion investigations;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">An investigation or inspection of or allegation of misconduct by a specific person licensed, certified, or registered by or an applicant for licensure, certification, or registration by a health occupations board or the Department;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(3) </span>
                
                    <span class="" style="">A disciplinary proceeding before a health occupations board or in any subsequent hearing, trial, or appeal of an action or board order to designated employees of the Department;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(4) </span>
                
                    <span class="" style="">The proceedings of any grand jury or additional grand jury that has been properly impaneled in accordance with <a href='/sections/11-1916.html'>§ 11‑1916</a>; and</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(5) </span>
                
                    <span class="" style="">A specific investigation of a specific dispenser or specific prescriber to an agent of the United States Drug Enforcement Administration with authority to conduct drug diversion investigations.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(c) </span>
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">In accordance with the Department’s regulations and applicable federal law and regulations, the Director may, at the Director’s discretion, disclose:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 3.75em">
            
                <p>
                
                    <span class="level-num" style="">(A) </span>
                
                    <span class="" style="">Information in the possession of the Program concerning a patient who is over the age of 18 years to that patient, or to the parent or legal guardian of a child aged 18 years or under, unless otherwise prohibited by District or federal law;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 3.75em">
            
                <p>
                
                    <span class="level-num" style="">(B) </span>
                
                    <span class="" style="">Information on a specific patient to a prescriber for the purpose of establishing the treatment history of the specific patient when the patient is either under care and treatment by the prescriber or the prescriber is initiating treatment of the patient;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 3.75em">
            
                <p>
                
                    <span class="level-num" style="">(C) </span>
                
                    <span class="" style="">Information on a specific patient to a dispenser for the purpose of establishing a prescription history to assist the dispenser in determining the validity of a prescription when the patient is seeking a covered substance from the dispenser or the facility in which the dispenser practices;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 3.75em">
            
                <p>
                
                    <span class="level-num" style="">(D) </span>
                
                    <span class="" style="">Information relevant to an investigation or regulatory proceeding of a specific dispenser or prescriber to other regulatory authorities concerned with granting, limiting, or denying licenses, certificates, or registrations to practice a health profession when the regulatory authority licenses the dispenser or prescriber, or the dispenser or prescriber is seeking licensure by a regulatory authority;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 3.75em">
            
                <p>
                
                    <span class="level-num" style="">(E) </span>
                
                    <span class="" style="">Information relevant to an investigation relating to a specific dispenser or prescriber who is a participating provider in the District Medicaid program, DC Health Care Alliance, or any other public health care program; information relating to an investigation relating to a specific patient who is currently eligible for and receiving, or who has been eligible for and has received medical assistance services; information relevant to the Medicaid Fraud Control Unit of the Office of the Inspector General, or to designated employees of the Department of Health Care Finance, as appropriate;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 3.75em">
            
                <p>
                
                    <span class="level-num" style="">(F) </span>
                
                    <span class="" style="">Information relevant to the determination of the cause of death of a specific patient to the designated employees of the Office of the Chief Medical Examiner; and</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 3.75em">
            
                <p>
                
                    <span class="level-num" style="">(G) </span>
                
                    <span class="" style="">Information for the purpose of bona fide research or education to qualified personnel; provided, that:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 5em">
            
                <p>
                
                    <span class="level-num" style="">(i) </span>
                
                    <span class="" style="">Data elements that would reasonably identify a specific patient, prescriber, or dispenser shall be deleted or redacted from the information before disclosure; and</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 5em">
            
                <p>
                
                    <span class="level-num" style="">(ii) </span>
                
                    <span class="" style="">Release of the information shall only be made pursuant to a written agreement between qualified personnel and the Director to ensure compliance with this chapter.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">For the purposes of a disclosure under paragraph (1)(B) or (C) of this subsection:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 3.75em">
            
                <p>
                
                    <span class="level-num" style="">(A) </span>
                
                    <span class="" style="">The request shall be made and the information shall be provided in the manner specified by the Director through rulemaking; and</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 3.75em">
            
                <p>
                
                    <span class="level-num" style="">(B) </span>
                
                    <span class="" style="">Notice shall be given to patients that the information described in paragraph (1)(B) or (C) of this subsection, as applicable, may be requested by a prescriber or dispenser participating with the Program.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(d) </span>
                
                    <span class="" style="">Confidential information that has been received, maintained, or developed by a health occupations board or disclosed by the health occupations board pursuant to this chapter shall not be available for discovery or court subpoena or introduced into evidence in any medical malpractice suit or other action for damages arising out of the provision of or failure to provide services; provided, that this section shall not be construed to inhibit any investigation or prosecution conducted pursuant to this chapter.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group annotations ">
        

    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">History</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">(Feb. 22, 2014, <a href='http://openlims.org/public/L20-66.pdf'>D.C. Law 20-66</a>, § 6, <a href='http://www.dcregs.dc.gov/Gateway/IssueList.aspx?IssueYear=2014'>61 DCR 7</a>.)</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Section references</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">This section is referenced in <a href='/sections/48-853.02.html'>§ 48‑853.02</a>.</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Legislative history of Law 20-66</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">See note to <a href='/sections/48-853.01.html'>§ 48‑853.01</a>.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group toc sep">
        

    
        <div class="line heading heading-1 " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">§ 48–853.06. Interoperability; information exchange with other prescription drug monitoring programs.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group primary-content ">
        

    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(a) </span>
                
                    <span class="" style="">The Director may enter into written agreements with other prescription drug monitoring programs, or a third party, approved by the Director, that operates an interstate prescription drug monitoring exchange, for the purpose of interoperability and the mutual exchange of information among prescription drug monitoring programs, and describing the terms and conditions for the sharing of prescription information under this section.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(b) </span>
                
                    <span class="" style="">The Director may provide prescription monitoring information pursuant to such agreements, which shall only use the information for the purposes allowed by this chapter.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(c) </span>
                
                    <span class="" style="">The Director may request and receive prescription drug monitoring information from other states’ prescription drug monitoring programs and may use the information under the provisions of this chapter.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group annotations ">
        

    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">History</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">(Feb. 22, 2014, <a href='http://openlims.org/public/L20-66.pdf'>D.C. Law 20-66</a>, § 7, <a href='http://www.dcregs.dc.gov/Gateway/IssueList.aspx?IssueYear=2014'>61 DCR 7</a>.)</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Legislative history of Law 20-66</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">See note to <a href='/sections/48-853.01.html'>§ 48‑853.01</a>.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group toc sep">
        

    
        <div class="line heading heading-1 " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">§ 48–853.07. Criteria for indicators of misuse; Director’s authority to disclose information; intervention.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group primary-content ">
        

    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(a) </span>
                
                    <span class="" style="">The Director may establish through rulemaking:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">Criteria for indicators of misuse; and</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">A method for analysis of data collected by the Program using the criteria for indicators of misuse.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(b) </span>
                
                    <span class="" style="">Upon the development of the criteria and data analysis, the Director may, in addition to the discretionary disclosure of information pursuant to this chapter, disclose information using the criteria that indicates potential misuse by recipients of covered substances to their specific prescribers for the purpose of intervention to prevent such misuse.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group annotations ">
        

    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">History</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">(Feb. 22, 2014, <a href='http://openlims.org/public/L20-66.pdf'>D.C. Law 20-66</a>, § 8, <a href='http://www.dcregs.dc.gov/Gateway/IssueList.aspx?IssueYear=2014'>61 DCR 7</a>.)</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Legislative history of Law 20-66</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">See note to <a href='/sections/48-853.01.html'>§ 48‑853.01</a>.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group toc sep">
        

    
        <div class="line heading heading-1 " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">§ 48–853.08. Immunity from liability.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group primary-content ">
        

    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(a) </span>
                
                    <span class="" style="">The Director and the employees of the Department shall not be liable for any civil damages resulting from the accuracy or inaccuracy of any information reported, compiled, or maintained by the Program pursuant to this chapter.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(b) </span>
                
                    <span class="" style="">The Director and the employees of the Department shall not be liable for any civil damages resulting from the disclosure of or failure to disclose any information in compliance with this chapter and the Department’s regulations.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(c) </span>
                
                    <span class="" style="">In the absence of gross negligence or willful misconduct, prescribers or dispensers complying in good faith with the reporting requirements of this chapter shall not be liable for any civil damages for any act or omission resulting from the submission of such required reports.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group annotations ">
        

    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">History</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">(Feb. 22, 2014, <a href='http://openlims.org/public/L20-66.pdf'>D.C. Law 20-66</a>, § 9, <a href='http://www.dcregs.dc.gov/Gateway/IssueList.aspx?IssueYear=2014'>61 DCR 7</a>.)</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Legislative history of Law 20-66</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">See note to <a href='/sections/48-853.01.html'>§ 48‑853.01</a>.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group toc sep">
        

    
        <div class="line heading heading-1 " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">§ 48–853.09. Unlawful disclosure of information and acts; disciplinary action authorized; penalties.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group primary-content ">
        

    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(a) </span>
                
                    <span class="" style="">It shall be unlawful for any person having access to the confidential information in possession of the Program or any data or reports produced by the Program to disclose the confidential information except as provided in this chapter. Any person who discloses this confidential information in violation of the provisions of this chapter shall be guilty of a misdemeanor upon conviction.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(b) </span>
                
                    <span class="" style="">It shall be unlawful for any person who lawfully receives confidential information from the Program to redisclose or use the confidential information in any way other than the authorized purpose for which the request was made. Any person who discloses confidential information in violation of this chapter shall be guilty of a misdemeanor upon conviction.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(c) </span>
                
                    <span class="" style="">Nothing in this section shall prohibit a person who prescribes or dispenses a covered substance required to be reported to the program from redisclosing information obtained from the Program to another prescriber or dispenser who has prescribed or dispensed a covered substance to the same patient.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(d) </span>
                
                    <span class="" style="">Unauthorized use or disclosure of confidential information received from the Program shall also be grounds for disciplinary action by the relevant health occupations board.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group annotations ">
        

    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">History</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">(Feb. 22, 2014, <a href='http://openlims.org/public/L20-66.pdf'>D.C. Law 20-66</a>, § 10, <a href='http://www.dcregs.dc.gov/Gateway/IssueList.aspx?IssueYear=2014'>61 DCR 7</a>.)</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Legislative history of Law 20-66</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">See note to <a href='/sections/48-853.01.html'>§ 48‑853.01</a>.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group toc sep">
        

    
        <div class="line heading heading-1 " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">§ 48–853.10. Rules.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group primary-content ">
        

    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">The Director, pursuant subchapter I of Chapter 5 of Title 2 [<a href='/sections/2-501.html'>§ 2‑501</a> et seq.], shall issue rules to implement the provisions of this chapter, including the establishment of criteria for granting waivers to the reporting requirements set forth in this chapter.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group annotations ">
        

    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">History</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">(Feb. 22, 2014, <a href='http://openlims.org/public/L20-66.pdf'>D.C. Law 20-66</a>, § 11, <a href='http://www.dcregs.dc.gov/Gateway/IssueList.aspx?IssueYear=2014'>61 DCR 7</a>.)</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Legislative history of Law 20-66</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">See note to <a href='/sections/48-853.01.html'>§ 48‑853.01</a>.</span>
                
                </p>
            
        </div>
    

    </div>

</div>

                        </div>
                    </div>
                </div>
            </div>
            <footer>
                <div class='container center'>
                    <p>This is a fast, unofficial interface to the
                        <a href='http://dccouncil.us/UnofficialDCCode'>Unofficial DC Code</a>.
                    </p>
                    <p>
                        <a href='https://github.com/dccouncil/simple-generator/issues'>See a problem? Report an issue.</a>
                        <a href='http://swiftype.com?ref=pb'>Search provided by Swiftype.</a>
                    </p>
                </div>
            </footer>
        </div>
        <script>
        ROOTDIR = '';
        </script>
        <script src='/js/jquery-1.11.0.min.js'></script>
        <script src='/js/search.js'></script>
        <script type="text/javascript">
        var Swiftype = window.Swiftype || {};
          (function() {
            Swiftype.key = 'NabUNfCzsj237fjyi55J';

            /** DO NOT EDIT BELOW THIS LINE **/
            var script = document.createElement('script'); script.type = 'text/javascript'; script.async = true;
            script.src = "//s.swiftypecdn.com/embed.js";
            var entry = document.getElementsByTagName('script')[0];
            entry.parentNode.insertBefore(script, entry);
          }());
        </script>
    </body>
</html>
